Immunovant, Inc. (IMVT)

Immunovant Stock Forecast

Stock Price Forecast

According to 7 professional analysts, the 12-month price target for Immunovant stock ranges from a low of $17 to a high of $53. The average analyst price target of $40.14 forecasts a 173.06% increase in the stock price over the next year.

Price Target: $40.14 (+173.06%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$17	$40.14	$45	$53
Change	+15.65%	+173.06%	+206.12%	+260.54%

Analyst Ratings

The average analyst rating for Immunovant stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	5	5	6	5	3	3
Buy	6	5	5	5	5	5
Hold	0	1	1	1	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	12	11	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Colin Bristow UBS	UBS	Strong Buy → Hold Downgrades $38 → $17	Strong Buy → Hold	Downgrades	$38 → $17	+15.65%	Apr 22, 2025
Yatin Suneja Guggenheim	Guggenheim	Strong Buy Reiterates n/a	Strong Buy	Reiterates	n/a	n/a	Mar 20, 2025
Jason Gerberry B of A Securities	B of A Securities	Strong Buy Maintains $38 → $33	Strong Buy	Maintains	$38 → $33	+124.49%	Mar 20, 2025
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $51	Strong Buy	Reiterates	$51	+246.94%	Mar 19, 2025
Yatin Suneja Guggenheim	Guggenheim	Strong Buy Reiterates n/a	Strong Buy	Reiterates	n/a	n/a	Mar 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.70B

Increased by 108.88%

from 814.35M

Revenue Next Year

n/a

from 1.70B

EPS This Year

-2.88

from -1.88

EPS Next Year

-3.12

from -2.88

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029	FY 2030
Period Ending	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027	Mar 31, 2028	Mar 31, 2029	Mar 31, 2030
Revenue	-	-	35.39M	250.83M	814.35M	1.70B
Revenue Growth	-	-	-	608.80%	224.66%	108.88%	-	-
EPS	-1.54	-1.22	-1.43	-1.71	-1.88	-2.88	-3.12	-3.28
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	15	15	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	n/a	n/a	123.8M
Avg	n/a	n/a	35.4M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-2.56	-2.57	-2.88
Avg	-2.88	-3.12	-3.28
Low	-3.03	-3.52	-3.77

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.